Objective: To characterize the cardiac angiotensin and endothelin (ET) system in compensated left ventricular hypertrophy due to long standing arterial hypertension and to assess the role of angiotensin and ET converting enzymes in mediating the observed changes of angiotensin and ET levels, respectively. Methods: We studied the left ventricular renin-angiotensin system (RAS) and ET system in 20-week-old male transgenic hypertensive TG(mREN2)27 rats, a model of the monogenic renin-dependent form of severe hypertension. Age-matched Sprague-Dawley rats served as controls. Results: TG(mREN2)27 rats exhibited left ventricular hypertrophy without signs of congestion. Transgene overexpression led to an activation of the tissue RAS with increased angiotensin II levels in spite of unchanged angiotensin converting enzyme (ACE) activity and ACE mRNA levels. ET-1 production was markedly increased in TG(mREN2)27 rats indicating that the ET-system was activated. Cardiac ET-1 in TG(mREN2)27 originated most likely from increased preproET-1 production because preproET-1 mRNA levels were increased but ET converting enzyme gene expression and activity were unchanged. Furthermore, ET-1 binding sites were significantly increased in TG(mREN2)27 rats without changes in K values and ET / ET receptor D A B ratios. ET receptor gene expression was not altered whereas ET receptor mRNA levels were up-regulated twofold in TG(mREN2)27
Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats a , b b a a 1. Introduction unresolved problem in experimental and clinical cardiology. A large body of clinical and experimental evidence Myocardial hypertrophy in response to hemodynamic supports an important role for the renin-angiotensin overload is an established risk factor for cardiovascular system (RAS). Recent in vitro studies suggest that morbidity and mortality. Data from the Framingham study endothelin-1 (ET-1), a potent vasoconstrictor and growth demonstrate that cardiac hypertrophy due to long standing factor for cardiomyocytes, is involved in the mechanism hypertension is associated with an increased incidence of by which angiotensin II (Ang II) induces cardiac hyheart failure [1] . However, identifying the biochemical pertrophy [2] . It has been shown that Ang II induces the basis of the pathological process that promotes the proexpression of ET-1 in isolated cardiomyocytes involving gression of ventricular dysfunction remains an important autocrine regulation via ET receptors [3] . In a first effort vivo, the effect of increased circulating Ang II on cardiac 2.2. Radioligand binding studies ET-1 synthesis has been investigated in rats after chronic Ang II infusion [4, 5] . However, these studies failed to ET-receptor density was determined as described previdetect increased cardiac ET-1 formation and it has been ously [9] . Non-specific binding was defined as binding not hypothesized that the cardiac ET system may require displaced by 10 mmol / l bosentan and was lower than 10% activation by the local rather than the circulating RAS of maximum total binding. ET-1 and BQ-123 competition [4, 6] .
curves were analyzed by the iterative curve fitting program The purpose of the present study was to investigate Graph Pad Prism (GraphPad software). From the ET-1 whether the cardiac RAS and ET system are co-activated competition curves, B and K values were calculated.
max D in hypertensive cardiomyopathy before onset of heart failure. We used a well-characterized monogenic model of 2.3. Myocardial angiotensin II content arterial hypertension, namely the TG(mREN2)27 rat. Previously, Rothermund et al. have shown that cardiac ET For determination of myocardial Ang II content, left mRNA levels were not increased at a very early stage of ventricular tissue samples were homogenized with a glasscardiac hypertrophy in TG(mREN2)27 rats but were teflon homogenizer in ice-cold homogenization buffer (10 significantly elevated in failing hearts [7] . This finding did mmol / l Tris-HCl, 1 mmol / l EDTA, 1 mmol / l dithionot answer the question whether activation of the ETthreitol, pH 7.4) including the protease inhibitors leupeptin system precedes manifestation of heart failure and, there-(0.5 mg / ml), aprotinin (0.5 mg / ml) and PMSF (1 mmol / fore, may account at least in part for progressive cardiac l). After centrifugation (100 0003g, 15 min), the resulting dysfunction. In the present study, we investigated alterasupernatant was purified on Sep-Pak C18 columns. The tions of cardiac angiotensin II and ET-1 generation, ET eluates were lyophilized and the dry residues were re-A and ET receptor density, and steady state mRNA expressolved in 1.2 ml Tris-HCl reconstitution buffer (pH 7.5).
B sion of preproET-1, ET receptors, and ET receptors in Ang II was determined with a commercially available A B 20-week-old TG(mREN2)27 rats with compensated left radioimmunoassay according to the instructions of the ventricular hypertrophy. For the first time, activities of manufacturer (Biermann, Bad Nauheim, Germany). The angiotensin and the endothelin converting enzymes, which sensitivity of the radioimmunoassay was 0.7 pg / ml and the have been considered to be rate limiting for Ang II and cross reactivity of the Ang II antibody was 0.14% for Ang I. endothelin synthesis, respectively, have been determined in left ventricular myocardium from TG(mREN2)27 rats.
Immunohistochemistry
Left ventricular tissue specimens obtained from TG(mREN2)27 rats were embedded in OCT (Miles Lab, 2. Methods USA), snap-frozen in liquid nitrogen, and stored at 2708C until used. Four-mm sections were cut, mounted on poly-L-2.1. Animals lysine-coated slides and dried at room temperature for 3 h. The sections were fixed in acetone / methanol (1:1, 2208C) Heterozygous transgenic TG(mREN2)27 animals and for 5 min, washed with PBS three times and incubated in Sprague-Dawley (SD) control rats were obtained from 10% normal sheep serum for 30 min at room temperature Møllegard (Denmark). The animals were handled in confollowed by incubation with monoclonal mouse anti-rat formity with the Guide for the Care and Use of Labora-ET-1 antibody (dilution 1:50) overnight at 48C. After three tory Animals published by the US National Institutes of more washes in PBS, the sections were stained using a Cy3 Health (NIH Publication No. 85-23, revised 1996) . conjugated secondary sheep anti-mouse antibody (Sigma, TG(mREN2)27 and SD rats were kept in a room at a dilution 1:1000). For negative controls, sections were temperature of 258C with 12 h light-dark cycle. The incubated with normal mouse IgG (Sigma) instead of the animals were kept on a standard laboratory animal diet and primary antibody. tap water ad libitum. SD rats were the animals into which the transgene was originally introduced. Systolic and 2.5. Collagen quantification diastolic blood pressures were measured by the tail-cuff method according to Pfeffer et al. [8] . Animals were
The hearts fixed in paraformaldehyde solution (4% w / v) weighed and killed by cervical dislocation at the age of 20 were processed for paraffin embedding. Coronal sections weeks. The hearts were rapidly removed, washed with (5 mm) of the median part of the left ventricle were saline, blotted dry with filter paper, weighed and immediobtained. Tissue sections were dewaxed with ethanol and ately frozen in liquid nitrogen. Samples were stored at stained with Sirius red F3BA (0.5% in saturated aqueous 2808C. Lung water content was determined by calculating picric acid, Aldrich). Collagen density was evaluated the difference between lung wet weight and dry weight throughout the inner third (subendocardial myocardium), after lyophilization.
the middle third (midmyocardium), and the outer third (subepicardial myocardium) of the circumference of the 2.9. Blot hybridization experiments left ventricle. From each of two nonconsecutive serial sections, five fields in each region of the heart (magnificaNorthern blots were prepared from 10 mg total RNA as 32 tion 320) were recorded by a digital camera (Nikon described previously [9] . A [ P] labelled 411 bp fragment 32 Corporation, Japan). The severity of interstitial fibrosis was of rat ANP cDNA and a [ P] labelled 571 bp fragment of evaluated after Sirius red staining with the use of the Scion rat preproET-1 cDNA, respectively, were used as a specific Image software (Scion Corporation, USA). Perivascular probe. fibrosis was estimated from cross sections of coronary arteries. A single investigator blinded to the experimental 2.10. Quantitative RT-PCR analysis of ET-receptor and groups performed the analysis.
ECE mRNA expression
Internal standard RNA with a deletion of 10-20% were 2.6. Tissue levels of immunoreactive ET-1 generated as described previously [9] . Two mg of the total RNA and 10 pg of mut ET , mut ET , mut ppET-1, or
Approximately 200 mg left ventricular tissue was mut ECE standard mRNA, respectively, were mixed and homogenized in five volumes of a phosphate homogenizareverse transcribed with random primers. The single tion buffer (0.14 mol / l NaCl, 2.6 mmol / l KCl, 8 mmol / l stranded cDNA was amplified by polymerase chain reNa HPO , 1.4 mmol / l KH PO , 1% Triton-X, pH 7.4). action (for primer sequences see Ref. [9] ). PCR-products The homogenates were then centrifuged at 100 0003g for were quantified by Southern blot technique and laser 60 min at 48C. Aliquots (200 ml; 2 mg protein) were densitometry (Image Quant). PCR-amplification has been assayed in duplicate using an ET-1 ELISA kit shown to be linear within a range of 28-40 cycles. Non-(Biomedica). This kit exhibits cross reactivity with other competitive amplification of GAPDH was used to demon-ET peptides as follows: ET-2 (100%), endothelin-3 strate equivalence of RNA-loading in RT-PCR reactions. (,5%), big ET 1-38 (,1%), big ET 22-38 (,1%).
Statistics

Tissue ACE activity assay
Data are expressed as mean6S.E.M. Statistical analysis was performed by Student t-test for unpaired observations. Assays were performed according to the method of A probability value ,0.05 was considered significant. Cushman and Cheung [10] . Aliquots of resuspended membranes were incubated with 10 mmol / l Hip-His-Leu for 30 min at 378C with and without 1 mmol / l enalapril. Enzyme activity was quantified by fluorometric measure-3. Results ment of hippurate cleavage from the substrate. ACE activities are expressed as moles (captopril inhibitable) 3.1. Characteristics of TG(mREN2)27 rats hippuryl acid formed per gram of protein per minute.
Cardiac morphological and functional parameters are summarized in Table 1 . Blood pressure was significantly 2.8. Tissue ECE activity assay higher in TG(mREN2)27 rats than in SD controls. Hearts of TG(mREN2)27 exhibited concentric hypertrophy but no Left ventricular membrane preparations (25 mg protein) dilation. No signs of congestion were observed in lungs or were incubated in the presence of big ET-1. The standard any other organ. Especially lung water was unchanged in enzyme reaction was carried out in 50 ml of assay buffer TG(mREN2)27 and SD. The ratio of left ventricular (50 mmol / l Tris-HCl, pH 7.0, 100 mmol / l NaCl, 5 weight to body weight was significantly elevated by about mg / ml BSA) containing 10 mmol / l big ET-1 at 378C in 40% in TG(mREN2)27 compared to SD. No differences in the absence and presence of the ECE-inhibitor phosphorrelative mass were observed in atria and right ventricles. amidon (100 mmol / l). After an incubation period of 3 h Heart rates were significantly increased in TG(mREN2)27 the reaction was stopped by adding 50 ml of 10 mmol / l compared to SD-controls. Left ventricular ANP mRNA EDTA. The amount of formed ET-1 was determined using expression, which has been related to the degree of left an ET-1 ELISA (Amersham) which exhibits cross reactiviventricular impairment, was significantly higher in ty to big ET-1 ,1%. Samples were diluted 1:1000 and the TG(mREN2)27 rats than in SD controls. Interstitial and ELISA-assay was performed according to the manufacturperivascular collagen content in left ventricles increased er's protocol. Ventricular membrane conversion of exogen-2.3-fold and 2.4-fold, respectively, in TG(mREN2)27 rats ous big ET-1 proved to be time-and protein-dependent compared to age-matched SD rats (Fig. 1) . Perivascular (linear up to 4 h and 60 mg membrane protein, data not fibrosis was accompanied by an increase in the thickness shown).
of the tunica media of coronary arteries (Fig. 1A , media II levels since ACE mRNA expression and ACE activity (Fig. 2) was unchanged in the hypertrophied myocardium 3.2. LV renin-angiotensin system of TG(mREN2)27 rats compared to SD controls.
Tissue Ang II concentrations were significantly in-3.3. LV endothelin system creased ( Fig. 2 ) in left ventricles of TG(mREN2)27 rats indicating a chronic activation of the RAS in the hyTo localize ET-1 and to elucidate cell type-specific pertrophied myocardium. Enhanced cardiac conversion of distribution patterns, immunohistochemical studies were (Fig. 3C) . These findings indicate that the remarkably increased expression of myocardial ET-1 originates from an increase in preproET-1 production rather than from an increase in ECE expression or activity. The characteristics of ET-receptors were assessed by competition binding experiments in left ventricular membrane preparations (Fig. 4) which allows investigation of phenotypic changes in various organs caused by the perturbation of one system, performed. Because our anti human ET-1 antibody proved namely the RAS. In TG(mREN2)27 rats overexpression of d not to be suitable for immunohistochemistry in rats, an the mouse renin Ren2 gene led to an activation of the antiserum was used from mice against rat ET-1, generoustissue RAS [11] with increased Ang II formation in the left ly provided by A. Giaid. Staining for ET-1 was observed ventricular myocardium. This occurred despite unchanged in endothelial cells, vascular smooth muscle cells and cardiac ACE activity and ACE mRNA expression. In cardiac myocytes (Fig. 3A) . Intensities were higher in contrast, plasma renin activities, plasma Ang I and plasma endothelial cells than in muscle cells. Tissue ET-1 content Ang II concentrations were unchanged which indicates that was quantified using a specific ET-1 ELISA without circulating RAS was not activated in TG(mREN2)27 rats significant cross-reactivity to precursor peptides. Left [11] . We have previously demonstrated that among ACEventricular ET-1 concentrations were significantly ininhibitors, AT1-receptor antagonists, b-adrenoceptor creased in TG(mREN2)27 rats (Fig. 3B) , which indicates blockers, and vasodilators, blockade of RAS was most that the ET system is markedly activated in the hyeffective to reduce left ventricular hypertrophy in pertrophied myocardium. Cardiac prepro-ET-1 mRNA TG(mREN2)27 rats despite comparable effects on blood concentrations were 1.8-fold higher in TG(mREN2)27 rats, pressure [12] . Cardiac hypertrophy was positively correwhereas the expression of ECE-1 mRNA (0.960.1 vs.
lated with cardiac angiotensinogen expression [13] . Taken together, these observations strongly suggest that cardiac activated in compensated LV hypertrophy in hypertrophy in TG(mREN2)27 rats is mediated, at least in TG(mREN2)27 rats at an age of 20 weeks. PreproET-1 part, by an activation of the local RAS.
mRNA expression and ET-1 concentrations were inUntil now, the role of the cardiac endothelin system for creased, whereas both endothelin converting enzyme-1 the progression of left ventricular hypertrophy into heart (ECE-1) mRNA expression and functional ECE activity failure rats has not been well characterized. It has been were unchanged in TG(mREN2)27 rats. Thus, elevated reported previously that the cardiac ET-system was not tissue ET-1 is most likely due to increased preproET-1 activated in 10-week-old TG(mREN2)27 rats although production rather than increased conversion of big ET-1. cardiac hypertrophy and compensated LV dysfunction Immunohistochemical staining showed that increased tisappears established by 10 weeks [7] . This finding argues sue ET-1 originates from both cardiac myocytes and against a role for the cardiac ET-system but it does not vascular cells. Interestingly, alterations of the cardiac ETanswer this question definitely. The present study, desystem found in TG(mREN2)27 rats resemble those genersigned to investigate alterations of the ET system immedially found in failing myocardium [14] . Like ately before onset of congestive heart failure, clearly TG(mREN2)27 rats, in experimental animal models and in demonstrates that the cardiac endothelin system is indeed patients with congestive heart failure ECE-1 expression was found to be unchanged, whereas preproET-1 gene activation of the cardiac ET system precedes the developexpression was increased which led to increased tissue ment of congestive heart failure. These data are in line ET-1 [9, 15] . Rothermund et al. have demonstrated that with the interpretation that ET-1 plays an important role in cardiac ET system activity is depressed in the very early the progression of left ventricular dysfunction. state of cardiac hypertrophy in TG(mREN2)27 rats [7] . In Although mechanical stretch has been shown to directly the decompensated state, the cardiac ET system was increase the release of ET-1 from myocardial cells, in vivo activated with increased ECE mRNA expression and ET studies demonstrate that pressure overload is not generally A receptor density in the failing left ventricles from associated with an activated cardiac ET system. Unlike TG(mREN2)27 rats [7] . The present study shows that an TG(mREN2)27 rats, several experimental animal models of pressure overload have shown normal ET-1 levels in the which occurs already at an age of 10 weeks. We have considered several mechanisms leading to contractile hypertrophied myocardium in the compensated state dysfunction, including altered MHC isoform expression, [16, 17] . In aortic banded rats cardiac ET-1 expression was altered SERCA / PLB expression and cardiac fibrosis [26] . transiently increased and returned to basal levels at day 4 Endothelin has been shown to act as a mitogen inducing in spite of persistent pressure overload [18, 19] . Overall the hypertrophy of cardiac myocytes [23] ; ET-1 impairs information available would suggest that other factors than 21 sarcoplasmic reticulum Ca handling [28] and modulates pressure overload per se may prove to be essential in ET fibroblast function and matrix protein synthesis [24] . From system activation. One of these factors may be the RAS. In these observations one could argue that activation of the cultured neonatal cardiomyocytes and cardiac fibroblasts cardiac ET system may promote disease progression from Ang II has been shown to stimulate autocrine secretion of cardiac hypertrophy to failure. In an attempt to answer this ET-1 which in turn may contribute to the growth promotquestion, the TG(mREN2)27 model has been used previing effects of Ang II [3, 20] . The present study together ously to compare the role of the cardiac endothelin system with these in vitro findings provide evidence for a role of in compensated left ventricular hypertrophy and in heart tissue Ang II to stimulate cardiac ET-1 synthesis.
failure [7] . It has been demonstrated that the cardiac Radioligand binding studies demonstrated that both left ET-system was activated in the failing hearts from 30-ventricular ET and ET receptors were significantly up-A B week-old transgenic rats but was not activated or even regulated in TG(mREN2)27 rats although ET receptor A depressed (with respect to the ET receptor expression) at A mRNA concentrations were unchanged. The reason for this an earlier age of 10 weeks [7] . Thus, activation of the discrepancy is not known. In the present study, total ET A cardiac endothelin system obviously occurs not before mRNA and ET receptor binding sites in the left ventricu-A arterial hypertension, left ventricular hypertrophy, and lar myocardium have been determined and it has not been systolic / diastolic dysfunction are established in differentiated between the cell types, like cardiac TG(mREN2)27 rats. The present study clearly shows that myocytes, fibroblasts, or vascular smooth muscle cells, activation of the cardiac endothelin system precedes overt which are known to express ET receptors. It is likely that A heart failure and is not just associated with the end-stage the ET receptor expression is regulated differentially in A heart failure phenotype. The mechanisms which trigger different cell types and we hypothesize that this may activation of the cardiac endothelin system during disease account for the obvious discrepancy of increased ET A progression in the TG(mREN2)27 model remain to be receptor number in spite of unchanged ET receptor A defined. One of these mechanisms may be the cross talk mRNA levels between the activated RAS and the ET system. In addition, Several findings suggest that RAS activation may inincreased wall stress may be involved. Stretch induces fluence ET receptor expression. Indeed, Ang II has been ET-1 in isolated cardiomyocytes and cultured endothelial reported to induce a heterologous up-regulation of ET B cells [29, 30] , but the role of mechanical load on myocarreceptors in rat cardiomyocytes [21] and ET receptors in A dial ET-1 expression in vivo is still unclear. rat vascular smooth muscle cells [22] . Most ET-1 effects In summary, the cardiac endothelin and angiotensin on cardiomyocytes are initiated through the ET receptor A systems are co-activated in compensated cardiac hypersubtype including induction of proto-oncogene expression trophy before onset of heart failure, and thus may be [23] . Moreover, ET-1 modulates fibroblast function, such involved in the mechanism by which cardiac remodelling as collagen turnover, via ET and ET receptor stimulation A B and progression of left ventricular dysfunction occur in [24] . Therefore, activation of the cardiac ET-system with TG(mREN2)27 rats. These findings provide evidence for a increased local ET-1 production and a significant uppotentially useful therapeutic approach by the use of ET regulation of ET-receptors, as revealed in the present antagonists to prevent long-term cardiac complications. study, may contribute to the left ventricular remodelling process present in TG(mREN2)27 rats leading to cardiac hypertrophy and fibrosis [25] .
